Tokyo, Japan

Hiroki Kurihara

This inventor holds 1 USPTO granted patent. Top assignee: Syntex (u.s.a.) Inc.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroki Kurihara. Retrieved from https://idiyas.com/inventor/hiroki-kurihara-kx4ffucx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroki Kurihara: Innovator in Gene Expression Technology

Introduction

Hiroki Kurihara is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of gene expression technology. His innovative work has led to the development of a unique patent that enhances the understanding of targeted gene expression.

Latest Patents

Hiroki Kurihara holds a patent for "Targeted gene expression using preproendothelin-1 promoters." This invention provides a vector for the expression of a nucleic acid cassette in bronchial epithelial and vascular endothelial cells. The vector comprises a segment of the 5'-flanking region of the preproendothelin-1 gene, upstream from the transcription start site, and the first exon of the preproendothelin-1 gene. The nucleic acid cassette is strategically located within the first exon, ensuring its expression in a sequential and positional relationship.

Career Highlights

Hiroki Kurihara is associated with Syntex (U.S.A.) Inc., where he continues to advance his research and innovations. His work has garnered attention in the scientific community, particularly for its potential applications in gene therapy and related fields.

Collaborations

Some of his notable coworkers include Paula Nanette Belloni and Charles Elliott Sigal. Their collaborative efforts contribute to the ongoing research and development in the area of gene expression.

Conclusion

Hiroki Kurihara's contributions to gene expression technology exemplify the impact of innovative thinking in scientific research. His patent and ongoing work at Syntex (U.S.A.) Inc. highlight the importance of targeted gene expression in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…